Caspase-activation pathways in apoptosis and immunity

Immunological Reviews

Volumn 193, Issue , 2003, Pages 10-21

  Creagh, Emma M ^a   Conroy, Helen ^a   Martin, Seamus J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 10; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; DEOXYADENOSINE TRIPHOSPHATE; ENZYME PRECURSOR; GRANZYME B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASES; ENZYME ACTIVATION; HUMANS; SIGNAL TRANSDUCTION;

EID: 0037833742     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2003.00048.x     Document Type: Review

References (87)

1. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian IL-1beta-converting enzyme. Cell 1993;75:641-652.
2. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316.
3. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16.
4. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem 1999;68:383-424.
5. Slee EA, Adrain C, Martin SJ. Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ 1999;6:1067-1074.
6. Green DR. Apoptotic pathways: the roads to ruin. Cell 1998;94:695-698.
7. Kumar S. Mechanisms mediating caspase activation in cell death. Cell Death Differ 1999;6:1060-1066.
8. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995;82:349-352.
9. Slee EA, et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8 and -10 in a caspase-9 dependent manner. J Cell Biol 1999;144:281-292.
10. Adrain C, Martin SJ. The mitochondrial apoptosome: a killer unleashed on the cytochrome seas. Trends Biochem Sci 2001;26:390-397.
11. Stennicke HR, Ryan CA, Salvesen GS. Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem Sci 2002;27:94-101.
12. Zheng TS, Hunot S, Kulda K, Flavell RA. Caspase knockouts: matters of life and death. Cell Death Differ 1999;6:1043-1053.
13. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of the apoptotic program in cell free extracts: requirement for dATP and cytochrome c. Cell 1996;86:147-157.
14. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding and activation. Mol Cell 2002;9:423-432.
15. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-1312.
16. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 2002;9:1031-1042.
17. Zou H, Li Y, Liu X, Wang X. An APAF-1. cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274:11549-11556.
18. Adrain C, Slee EA, Harte MT, Martin SJ. Regulation of apoptotic protease activating factor-1 oligomerization and apoptosis by the WD-40 repeat region. J Biol Chem 1999;274:20855-20860.
19. Li K, et al. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 2000;101:389-399.
20. Cecconi F, Alvarez-Bolando G, Meyer BI, Roth KA, Gruss P. Apaf-1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 1998;94:727-737.
21. Yoshida H, et al. Apaf-1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998;94:739-750.
22. Hakem R, et al. Differential requirement for caspase-9 in apoptotic pathways in vivo. Cell 1998;94:339-352.
23. Kuida K, et al. Reduced apoptosis and cytochrome c mediated caspase activation in mice lacking caspase-9. Cell 1998;94:325-337.
24. Ashkenazi A, Dixit VM. Death receptors: signalling and modulation. Science 1998;281:1305-1308.
25. Muzio M, et al. FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death inducing signaling complex. Cell 1996;85:817-827.
26. varfolomeev EE, et al. Targeted disruption of the caspase-8 gene ablates cell death induction by the TNF receptors, Fas/Apo-1 and DR3 and is lethal perinatally. Immunity 1998;9:267-276.
27. Yeh WC, et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998;279:1954-1958.
28. Kischkel FC, et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 2001;276:46639-46646.
29. Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 2001;98:13884-13888.
30. Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signaling complexes in a FADD-dependent manner but cannot functionally substitute caspase-8. EMBO J 2002;21:4520-4530.
31. Scaffidi C, et al. Two CD95 (APO-1/Fas) signalling pathways. EMBO J 1998;17:1675-1687.
32. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X, Bid, a Bcl-2 interacting protein mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481-490.
33. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of Bid by caspase-8 mediates mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491-501.
34. Froelich CJ, Dixit VM, Yang X. Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immunol Today 1998;19:30-36.
35. Martin SJ, et al. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO J 1996;15:2407-2416.
36. Darmon AJ, Ley TJ, Nicolson DW, Bleakley RC. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation. J Biol Chem 1996;271:21709-21712.
37. Van de Craen M, et al. Cleavage of caspase family members by granzyme B: a comparative study in vitro. Eur J Immunol 1997;27:1296-1299.
38. Medema JP, et al. Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis. Eur J Immunol 1997;27:3492-3498.
39. Atkinson EA, et al. Cytotoxic T lymphocyte-assisted suicide. Caspase-3 activation is primarily the result of the direct activation of granzyme B. J Biol Chem 1998;273:21261-21266.
40. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, Salvesen GS. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J Biol Chem 1997;272:7797-7800.
41. Barry M, et al. Granzyme B short circuits the need for caspase-8 activity during granule-mediated cytotoxic T lymphocyte killing by directly cleaving Bid. Mol Cell Biol 2000;20:3781-3794.
42. Heibein JA, et al. Granzyme B mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J Exp Med 2000;192:1391-1402.
43. Sutton VR, et al. Initiation of apoptosis by granzyme B requires direct cleavage of Bid, but not direct granzyme B-mediated caspase activation. J Exp Med 2000;192:1403-1414.
44. Pinkoski MJ, et al. Granzyme B mediated apoptosis proceeds predominantly through a Bcl-2 inhibitable mitochondrial pathway. J Biol Chem 2001;276:12060-12067.
45. Heusel JN, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994;76:977-987.
46. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA. Induction of apoptosis by the mouse Nedd-2 gene, which encodes a protein similar to the product of the C. elegans cell death gene ced-3 and the mammalian IL-1beta-converting enzyme. Genes Dev 1994;8:1613-1626.
47. Wang L, Miura M, Bergeron L, Zhu H, Yuan J. Ich-1, an ICE/Ced-3 related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994;78:739-750.
48. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002;279:1352-1354.
49. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 2002;277:13430-13437.
50. Robertson JD, Enoksson M, Suomela M, Zhivotovvsky B, Orrenius S. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002;277:29803-29809.
51. Read SH, Baliga BC, Ekery PG, Vaux DL, Kumar S. A novel Apaf-1-independent putative caspase-2 activation complex. J Cell Biol 2002;159:739-745.
52. Duan H, Dixit VM. RAIDD is a new death adaptor molecule. Nature 1997;385:86-89.
53. Korhonen L, Hamner S, Olsson PA, Lindholm D. Bcl-2 regulates the levels of the cysteine proteases ICH and CPP32/Yama in human neuronal precursor cells. Eur J Neurosci 1997;9:2489-2496.
54. Haviv R, Lindenboim L, Yuan J, Stein R. Need for caspase-2 in apoptosis of growth factor-deprived PC12 cells. J Neurosci Res 1998;52:491-497.
55. Bergeron L, et al. Defects in regulation of apoptosis in caspase-2 deficient mice. Genes Dev 1998;12:1304-1314.
56. O'Reilly L, et al. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on Apaf-1 and caspase-9. Cell Death Differ 2002;9:832-841.
57. Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 2000;403:98-103.
58. Morishima N, Nakanishi K, Takenouchi H, Shibata T, Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. J Biol Chem 2002;277:34287-34294.
59. Rao RV, et al. Coupling endoplasmic reticulum stress to the cell death program: an apaf-1 independent intrinsic pathway. J Biol Chem 2002;277:21836-21842.
60. Fischer H, Koenig U, Eckhart L, Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 2002;293:722-726.
61. Thornberry N, et al. A novel heterodimeric cysteine protease is required for interlenkin-1 β processing in monocytes. Nature 1992;356:768-774.
62. Miura M, Zhu H, Rotello R, Hartweig E, Yuan J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993;75:653-660.
63. Li P, et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995;80:401-411.
64. Kiuda K, Lippke J, Ku G, et al. Altered cytokine export and apoptosis in mice deficient interleukin-1β converting enzyme. Science 1995;267:2000-2002.
65. Gu Y, Wu J, Faucheu C, et al. Interleukin- 1β converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J 1995;14:1923-1931.
66. Ayala J, Yamin T, Egger L, Chin J, Kostura MJ, Miller D. IL-1β-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J Immunol 1994;153:2592-2599.
67. Miossec C, Decoen M, Durand L, Fassy F, Din-Hercend A. Use of monoclonal antibodies to study interleukin-1β-converting enzyme expression: only precursor forms are detected in interleukin-1β-secreting cells. Eur J Immunol 1996;26:1032-1042.
68. Singer II, et al. The interleukin-1beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J Exp Med 1995;182:1447-1459.
69. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of pro IL-1β. Mol Cell 2002;10:417-426.
70. Wang S, Miura M, Jung Y, Zhu H, Li E, Yuan J. Murine caspase-11, an ICE-interacting protease is essential for the activation of ICE. Cell 1998;92:501-509.
71. Faucheu C, et al. A novel human protease similar to the interleukin-1β converting enzyme induces apoptosis in transfected cells. EMBO J 1995;14:1914-1922.
72. Kamens J, et al. Identification and characterization of ICH-2, a novel member of the interleukin-1β-converting enzyme family of cysteine proteases. J Biol Chem 1995;270:15250-15256.
73. relIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem 1995;270:1580-15876.
74. Faucheu C, Blanchet A, Collard-Dutilleul V, Lalanne J, Hercend A. Identification of a cysteine protease closely related to interleukin-1β-converting enzyme. Eur J Biochem 1996;236:207-213.
75. Fassy F, et al. Enzymatic activity of two caspases related to interleukin-1β-converting enzyme. Eur J Biochem 1998;253:76-83.
76. Lin X, Choi M, Porter A. Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma. J Biol Chem 2000;275:39920-39926.
77. Dinarello C. Interleukin-1. Cytokine Growth Factor Rev 1997;8:253-265.
78. Thome M, et al. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol 1998;8:885-888.
79. McCarthy J, Ni J, Dixit V. RIP2 is a Novel NF-κB-activating and cell death-inducing kinase. J Biol Chem 1998;273:16968-16975.
80. Kobayashi K, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002;416:194-199.
81. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 2002;416:190-194.
82. Poyet J, Srinivasula S, Tnani M, Razmara M, Fernandes-Alnemri T, Alnemri E. Identification of Ipaf, a human caspase-1 activating protein related to Apaf-1. J Biol Chem 2001;276:28309-28313.
83. Grenier J, et al. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NFκB and caspase-1. FEBS Lett 2002;530:73-78.
84. Wang L, et al. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NFκB and caspase-1-dependent cytokine processing. J Biol Chem 2002;277:29874-29880.
85. Manji GA, et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappaB. J Biol Chem 2002;277:11570-11575.
86. Druilhe A, Srinivasula S, Razmara M, Abroad M, Alnemri E. Regulation of IL-1β generation by pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ 2001;8:649-657.
87. Lee S, Stehlik C, Reed J. COP, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J Biol Chem 2001;276:34495-34500.